United States Department Of Health And Human Services

This resource showcases public sites that have been supplied with COVID-19 therapeutics procured by the US government under the Emergency Use Authorization (EUA) from the FDA. The authorized oral antiviral treatments include Lagevrio (molnupiravir), Paxlovid, and Renal Paxlovid, aimed at treating mild to moderate cases of COVID-19. Additionally, it features outpatient Veklury (remdesivir) provider locations that have chosen to be listed in the locator tool. It's important to note that while outpatient Veklury (remdesivir) is available commercially, it is not currently distributed by the US Government.

Intake Procedure: Visit the website.

Fees: There is no cost for the oral antiviral therapies Lagevrio (molnupiravir), Paxlovid, and Renal Paxlovid, but Veklury (remdesivir) may incur costs related to the medication for patients.